4.6 Article

Recognition of Alzheimer's disease and Mild Cognitive Impairment with multimodal image-derived biomarkers and Multiple Kernel Learning

期刊

NEUROCOMPUTING
卷 220, 期 -, 页码 98-110

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.neucom.2016.08.041

关键词

Alzheimer's disease; Multiple Kernel Learning; Mutlimodal fusion; Diagnosis; Local features; DTI; MD maps; CHFs; Imaging biomarkers

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) [U01 AG024904]
  2. National Institute on Aging
  3. National Institute of Biomedical Imaging and Bioengineering
  4. Alzheimers Association
  5. Alzheimers Drug Discovery Foundation
  6. BioClinica, Inc.
  7. Biogen Idec Inc.
  8. Bristol-Myers Squibb Company
  9. Eisai Inc.
  10. Elan Pharmaceuticals, Inc.
  11. Eli Lilly and Company
  12. F. Hoffmann-La Roche Ltd.
  13. GE Healthcare
  14. Innogenetics, N.V.
  15. IXICO Ltd.
  16. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  17. Johnson & Johnson Pharmaceutical Research & Development LLC.
  18. Medpace, Inc.
  19. Merck Co., Inc.
  20. Meso Scale Diagnostics, LLC.
  21. NeuroRx Research
  22. Novartis Pharmaceuticals Corporation
  23. Pfizer Inc.
  24. Piramal Imaging
  25. Servier
  26. Synarc Inc.
  27. Takeda Pharmaceutical Company
  28. Canadian Institutes of Health Research

向作者/读者索取更多资源

Computer-Aided Diagnosis (CAD) of Alzheimer's disease (AD) has drawn the attention of computer vision research community over the last few years. Several attempts have been made to adapt pattern recognition approaches to specific neuroimaging data such as Structural MRI (sMRI) for early AD diagnosis. One strategy is to boost the discrimination power of such approaches by integrating complementary imaging modalities in a single learning framework. Diffusion Tensor Imaging (DTI) is a new and promising modality giving complementary information to the anatomical MRI. However, including relevant DTI information from such modality is a challenging problem. In this paper, we propose to extract local image-derived biomarkers from DTI and sMRI to construct multimodal AD signatures. To assess the relevance of such modalities as well as to optimize the classifier, we integrate complementary information using a Multiple Kernel Learning (MKL) framework for AD subjects recognition. To evaluate our method, we perform experiments on a subset from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Both T1-weighted MRI and Mean Diffusivity (MD) maps from the DTI modality of 45 AD patients, 52 Normal Control (NC) and 58 Mild Cognitive Impairment (MCI) subjects have been used. The obtained results indicate that our multimodal approach yields significant improvement in accuracy over using each single modality independently. The classification accuracies obtained by the proposed method are 90.2%, 79.42% and 76.63% for respectively AD vs. NC, MCI vs. NC and AD vs. MCI binary classification problems. For the MCI classification problem, the proposed fusion framework leads to an average increase about at least 9% for the accuracy, 5% for the specificity and 15% for the sensitivity. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据